INDEPENDENT THINKING. WHOLE-FOOD LIVING.NO ANIMALS / NO OIL
THENANODIET
← THE EVIDENCE INDEX

The Study Library.

8,456 peer-reviewed studies, each with a short note written from its published abstract: what kind of study it was, who took part, what was measured and what the authors reported. Observational studies show associations, not proof.

People assigned to a diet, food or program and measured.

287 studies · page 8 of 12

2008 / Randomized controlled trial

Evening meals with barley kernel bread or added barley fiber and resistant starch improved breakfast glucose tolerance and inflammatory markers in healthy adults.

Fifteen healthy subjects consumed cereal-based bread evening meals varying in GI and indigestible carbohydrates to assess effects on a subsequent standardized breakfast. Evening meals with barley kernel-based bread or white wheat bread (WWB) enriched with barley fiber and resistant starch improved glucose tolerance at breakfast compared with unsupplemented WWB (P < 0.05). Following barley-kernel bread, IL-6 was lower (P < 0.01) and adiponectin was higher (P < 0.05) compared with WWB. Glucose response at breakfast was inversely correlated with colonic fermentation (r = -0.25; P < 0.05) and GLP-1 (r = -0.26; P < 0.05), while breath hydrogen correlated positively with satiety (r = 0.27; P < 0.01) and inversely with gastric emptying rate (r = -0.23; P < 0.05).

Nilsson AC, Ostman EM, Holst JJ, et al. J Nutr, 2008. PMID 18356328

2008 / Comparative crossover trial

In functional dyspepsia, a high-fat meal induced more nausea and pain than a high-carbohydrate meal, alongside higher CCK and lower PYY levels.

In 8 FD patients and 8 healthy controls, dyspeptic symptoms, appetite perceptions, plasma hormones, and antral area were evaluated on three separate days after high-carbohydrate, high-fat (500 kcal/400 g), or low-nutrient control (180 kcal/400 g) meals, followed by energy intake quantification 60 minutes later. In FD patients, nausea (P < 0.01) and pain (P = 0.05) were greater after the high-fat meal compared to high-carbohydrate and control meals and compared to healthy subjects. Fasting CCK and high-fat-stimulated CCK (P < 0.01) were higher, while fasting and postprandial PYY were lower (P < 0.001) in FD patients than controls. Fasting antral area was larger in FD (P < 0.05), but postprandial antral area, ghrelin levels, and subsequent energy intake did not differ between groups.

Pilichiewicz AN, Feltrin KL, Horowitz M, et al. Am J Gastroenterol, 2008. PMID 18775003

2008 / Randomized controlled trial

Green tea extract lowered the recurrence of colorectal adenomas following polypectomy.

In a randomized trial, patients who had colorectal adenomas removed and confirmed clean colon at 1 year were assigned to 1.5 g green tea extract daily (n=71) or no supplementation (n=65) for 12 months. Among the 125 patients completing follow-up colonoscopy, the incidence of metachronous adenomas was 15% (9 of 60) in the green tea extract group versus 31% (20 of 65) in controls (relative risk, 0.49; 95% CI, 0.24-0.99; P < 0.05). Relapsed adenoma size was also significantly smaller in the supplemented group (P < 0.001), with no serious adverse events reported.

Shimizu M, Fukutomi Y, Ninomiya M, et al. Cancer Epidemiol Biomarkers Prev, 2008. PMID 18990744

2007 / Randomized crossover trial and preclinical study

Coadministration of zinc carnosine led to no significant increase in indomethacin-induced gut permeability in healthy volunteers.

In a randomized crossover trial of 10 healthy volunteers, indomethacin caused a threefold increase in gut permeability in the control arm, with lactulose:rhamnose ratios shifting from mean (SEM) 0.35 (0.035) to 0.88 (0.11) after 5 days (p<0.01). In contrast, no significant increase in gut permeability was seen when zinc carnosine was coadministered. In accompanying preclinical work, zinc carnosine stimulated epithelial cell migration and proliferation and reduced gastric and small-intestinal injury.

Mahmood A, FitzGerald AJ, Marchbank T, et al. Gut, 2007. PMID 16777920

2007 / Randomized, double-blind, placebo-controlled crossover trial

Erythritol ingested in a liquid was better tolerated with significantly fewer gastrointestinal symptoms and less watery feces compared to xylitol.

Sixty-four healthy adults consumed 45 g sucrose or 20, 35, and 50 g of erythritol or xylitol dissolved in water in random order with 7-day washout periods. Compared to 45 g sucrose, 50 g xylitol significantly increased reports of nausea (P<0.01), bloating (P<0.05), borborygmi (P<0.005), colic (P<0.05), watery feces (P<0.05), and total bowel movement frequency (P<0.01), while 35 g xylitol increased watery feces (P<0.05). Conversely, 50 g erythritol only significantly increased nausea (P<0.01) and borborygmi (P<0.05), with 20 g and 35 g causing no significant increase in GI symptoms. At all intake levels, xylitol produced significantly more watery feces than erythritol.

Storey D, Lee A, Bornet F, et al. Eur J Clin Nutr, 2007. PMID 16988647

2007 / Randomized double-blind placebo-controlled trial

Oral alpha-galactosidase reduced intestinal gas and symptoms after a bean-rich meal.

Eight healthy volunteers consumed 300 GalU, 1200 GalU of alpha-galactosidase, or placebo alongside a test meal containing 420 g of cooked beans. Over an 8-hour period, 1200 GalU significantly lowered breath hydrogen excretion and flatulence severity. In addition, both the 300 and 1200 GalU doses significantly decreased overall gas-related symptom scores compared to placebo.

Di Stefano M, Miceli E, Gotti S, et al. Dig Dis Sci, 2007. PMID 17151807

2007 / Sequential dietary intervention trial

Reducing carbohydrate intake in obese individuals significantly decreased fecal butyrate concentrations and butyrate-producing bacteria.

Nineteen healthy, obese volunteers were given three diets sequentially: a 3-day maintenance diet (399 g carbohydrate/day), followed by 4 weeks of high-protein/medium-carbohydrate (164 g/day), and 4 weeks of high-protein/low-carbohydrate (24 g/day). Total fecal short-chain fatty acids significantly fell from 114 mM to 74 mM and 56 mM (P < 0.001), with a disproportionate drop in butyrate from 18 mM to 9 mM and 4 mM (P < 0.001). Concurrently, the Roseburia spp. and Eubacterium rectale subgroup decreased from 11% to 8% and 3% (P < 0.001), and bifidobacteria dropped from 4% to 2.1% and 1.9% (P = 0.026).

Duncan SH, Belenguer A, Holtrop G, et al. Appl Environ Microbiol, 2007. PMID 17189447

2007 / Randomized crossover trial

Higher calorie density increased esophageal acid exposure, while high dietary fat increased reflux symptom frequency in patients with reflux symptoms.

In 15 patients with reflux symptoms, a catheter-free system monitored esophageal pH over 4 days across 4 dietary conditions: high-fat (50%) vs low-fat (25%), and high-calorie (1000 kcal) vs low-calorie (500 kcal). Esophageal acid exposure was higher during the high-calorie than the low-calorie diet (mean, 8.6% +/- 2.0% vs 5.2% +/- 1.4% time pH < 4/24 h; P < .01), with no difference between high-fat and low-fat diets (8.6% +/- 2.0% vs 8.2% +/- 1.6%; P = NS). Conversely, reflux symptom frequency was unaffected by calorie density (P = NS) but was significantly increased by the high-fat compared with the low-fat diet (median, 11 vs 6; P < .05). Meal consistency had no effect.

Fox M, Barr C, Nolan S, et al. Clin Gastroenterol Hepatol, 2007. PMID 17363334

2007 / Prospective double-blind placebo-controlled randomized trial

Enteric-coated peppermint oil for 4 weeks significantly improved symptoms in patients with irritable bowel syndrome.

Fifty-seven patients with irritable bowel syndrome were randomly assigned to receive enteric-coated peppermint oil (two capsules twice daily) or placebo for 4 weeks, with symptoms assessed at baseline (T0), week 4 (T4), and 4 weeks post-therapy (T8). At T4, 75% of the peppermint oil group achieved a >50% reduction in baseline total IBS symptoms score compared with 38% in the placebo group (P<0.009). The total symptoms score dropped significantly in the peppermint oil group from 2.19+/-0.13 at T0 to 1.07+/-0.10 at T4 and 1.60+/-0.10 at T8 (P<0.01 vs T0), whereas no change occurred with placebo.

Cappello G, Spezzaferro M, Grossi L, et al. Dig Liver Dis, 2007. PMID 17420159

2007 / Intervention trial with in vitro experiments

A high red meat diet significantly increased nitrosyl iron and nitrosothiols in human ileal and fecal samples compared to a vegetarian diet.

Volunteers were fed a high red meat or a vegetarian diet, and fecal and ileal samples were analyzed for nitrosyl iron, nitrosothiols, and heme, alongside in vitro gastric simulations. Nitrosyl iron and nitrosothiols were significantly increased in ileal and fecal samples following the high red meat diet compared with the vegetarian diet (p < 0.0001). Significantly more nitrosyl iron than nitrosothiols was present in ileal (p < 0.0001) and fecal (p < 0.001) samples. Fecal nitrosyl iron strongly correlated with heme (0.776; p < 0.0001), and ESR confirmed nitrosyl heme in feces after the high red meat diet.

Kuhnle GG, Story GW, Reda T, et al. Free Radic Biol Med, 2007. PMID 17761300

2006 / Dietary intervention studies (pooled analysis)

Dietary red meat and fecal ATNC levels were not significantly associated with fecal water genotoxicity in human samples.

Fecal water samples were collected from 21 individuals across two studies who consumed diets containing varying amounts of red meat, protein, heme, and iron to assess genotoxicity using two Comet assay protocols. Fecal water genotoxicity showed no significant effect from diet (P > 0.20), mean transit time (P = 0.588), or weight (P = 0.705), but had a significant effect of age (P = 0.019). There was no significant correlation between fecal homogenate ATNC concentrations and fecal water genotoxicity (r = 0.04, P = 0.74). ATNC levels were significantly lower in fecal water (272 microg/kg) than in fecal homogenate (895 microg/kg) (P < 0.0001).

Cross AJ, Greetham HL, Pollock JR, et al. Environ Mol Mutagen, 2006. PMID 16304669

2006 / Interventional elimination diet and double-blind food challenge study

Food intolerance-related constipation in children was characterized by proctitis, higher anal resting pressure, and a thinner rectal mucus gel layer.

Thirty-six consecutive children with chronic constipation underwent an elimination diet, a subsequent double-blind food challenge, rectal biopsy, and anorectal manometry. Fourteen patients were identified with cow's milk intolerance and three with multiple food intolerance; their stool frequency normalized on the elimination diet and constipation recurred upon challenge. Food-intolerant patients displayed significantly higher mucosal erosions, intra-epithelial lymphocytes, eosinophils, higher anal sphincter resting pressure, lower critical volume, and a significantly lower rectal mucus gel layer thickness compared to other subjects. These histology and manometry abnormalities disappeared during the elimination diet.

Iacono G, Bonventre S, Scalici C, et al. Eur J Gastroenterol Hepatol, 2006. PMID 16394795

2006 / Randomized crossover trial

A high red meat diet significantly increased fecal N-nitrosocompounds and colonic DNA adducts compared to a vegetarian diet in human volunteers.

In a randomized crossover trial, human volunteers consumed high red meat (420 g), vegetarian, and high red meat plus high-fiber diets for 15 days in a controlled volunteer suite. In 21 volunteers, endogenous formation of apparent total N-nitrosocompounds (ATNC) in feces significantly increased on the red meat diet compared with the vegetarian diet (P < 0.0001). Colonic exfoliated cells showed a significantly higher percentage staining positive for O(6)-carboxymethyl guanine (O(6)CMG) adducts on the high red meat diet (P < 0.001), with intermediate levels in 13 volunteers on the high-fiber, high red meat diet. Fecal ATNC correlated positively with the percentage of O(6)CMG-positive cells (r(2) = 0.56, P = 0.011).

Lewin MH, Bailey N, Bandaletova T, et al. Cancer Res, 2006. PMID 16452248

2006 / Intervention study

Up to 85% of ingested blueberry anthocyanins reached ileostomy bags, compared to 0 to 33% of apple polyphenols.

Healthy ileostomy volunteers followed a polyphenol-free diet and then consumed either polyphenol-rich cloudy apple juice or anthocyanin-rich blueberries. Polyphenols in ileostomy effluent were identified and quantified using HPLC techniques. Most orally administered apple polyphenols were absorbed or metabolized in the small intestine, with 0% to 33% recovered in ileostomy bags (excretion peaking at 2 hours). In contrast, up to 85% of the blueberry anthocyanins studied were recovered in the ileostomy bags, depending on the sugar moiety.

Kahle K, Kraus M, Scheppach W, et al. Mol Nutr Food Res, 2006. PMID 16548015

2006 / Randomized crossover trial

Fermentable carbohydrates ingested at breakfast improved glucose tolerance at a subsequent standard lunch eaten 5 hours later.

Ten healthy volunteers consumed three breakfast test meals (sponge cakes made with amylopectin plus cellulose [HGI], amylopectin plus lactulose [HGI-Lac], or amylose plus cellulose [LGI]), followed 5 hours later by a standard lunch containing 93 g available carbohydrates. Both the HGI-Lac and LGI breakfast meals improved glucose tolerance at lunch. For the HGI-Lac meal, this improvement occurred alongside low nonesterified fatty acid (NEFA) concentrations and delayed gastric emptying.

Brighenti F, Benini L, Del Rio D, et al. Am J Clin Nutr, 2006. PMID 16600933

2006 / Randomized controlled trial

Aloe vera did not provide evidence of benefit for irritable bowel syndrome.

In a randomized controlled trial, 58 secondary care patients with irritable bowel syndrome took aloe vera or placebo for one month. Symptom response occurred in 35% (11 of 31) of the aloe vera group and 22% (6 of 27) of the placebo group at one month (p = 0.763). Researchers found no evidence that aloe vera improved symptoms overall, though a trend toward response appeared in diarrhea-predominant patients (p = 0.07).

Davis K, Philpott S, Kumar D, et al. Int J Clin Pract, 2006. PMID 16749917

2006 / Clinical trial

Vegetarians exhibited a higher prevalence of equol producers than nonvegetarians.

A clinical cohort of 41 healthy adults (29 vegetarians and 12 nonvegetarians) drank 500 mL of soy milk daily for 3 consecutive days to evaluate equol-producer status via urinary and serum isoflavones. A log10-transformed urinary S-equol to daidzein ratio cutoff of -1.75 was defined. Using this threshold, 59% of vegetarians were equol producers compared with 25% of nonvegetarian adults.

Setchell KD, Cole SJ J Nutr, 2006. PMID 16857839

2006 / Randomized crossover trial

Dietary modulation using vegetarian, low-meat, and high-meat diets produced distinct urinary metabolic phenotype signatures in healthy men.

Twelve healthy men consumed 'vegetarian', 'low meat', and 'high meat' diets in randomized order for continuous 15-day periods with 7-day washout intervals. 1H NMR spectroscopy of three consecutive 24-hour urine collections (days 13-15) revealed distinct metabolic profiles. Creatine, carnitine, acetylcarnitine, and trimethylamine-N-oxide (TMAO) were elevated during the high-meat period, whereas p-hydroxyphenylacetate was higher following the vegetarian diet compared to meat diets, indicating altered bacterial composition or metabolism.

Stella C, Beckwith-Hall B, Cloarec O, et al. J Proteome Res, 2006. PMID 17022649

2006 / Randomized controlled trial

Curcumin reduced relapse rates and improved clinical measures in quiescent ulcerative colitis.

In a randomized trial of 89 participants with quiescent ulcerative colitis, participants received 2 g daily of curcumin or placebo alongside standard therapy for 6 months. Among per-protocol participants, 4.65% (2 of 43) in the curcumin group relapsed compared to 20.51% (8 of 39) in the placebo group (P = 0.040; intention-to-treat P = 0.049). Curcumin also significantly improved both the clinical activity index (P = 0.038) and the endoscopic index (P = 0.0001).

Hanai H, Iida T, Takeuchi K, et al. Clin Gastroenterol Hepatol, 2006. PMID 17101300

2006 / Randomized crossover trial (plus rat studies)

A heme-supplemented diet doubled urinary DHN-MA excretion in a randomized crossover human study.

Researchers evaluated urinary 8-iso-PGF(2)alpha and DHN-MA across two rat studies and a randomized crossover human trial testing four diets (60 g/d red meat baseline, 120 g/d red meat, baseline with heme iron, and baseline with non-heme iron). In humans, the heme-supplemented diet led to a 2-fold increase in urinary DHN-MA (P < 0.001), while 8-iso-PGF(2)alpha did not increase. In rats, high-heme diets dramatically increased DHN-MA in parallel with preneoplastic lesions (P < 0.0001) and moderately increased 8-iso-PGF(2)alpha (P < 0.0001).

Pierre F, Peiro G, Taché S, et al. Cancer Epidemiol Biomarkers Prev, 2006. PMID 17119057

2006 / Intervention trial with lean and obese comparisons

The proportion of gut Bacteroidetes is lower in obese people and increases with weight loss on two types of low-calorie diets.

Researchers compared dominant gut bacteria between obese and lean individuals and evaluated changes during weight loss. The relative proportion of Bacteroidetes was decreased in obese people compared with lean people. This proportion increased with weight loss achieved through two types of low-calorie diets.

Ley RE, Turnbaugh PJ, Klein S, et al. Nature, 2006. PMID 17183309

2005 / Single-blind, randomized, multicenter, placebo-controlled 2x2 factorial trial

A reduced microparticle diet did not improve remission or clinical response in patients with active Crohn's disease.

Eighty-three patients with active Crohn's disease were randomized in a 2 x 2 factorial design to a diet low or normal in microparticles and/or calcium for 16 weeks, alongside a tapering 6-week prednisolone regimen, followed by 36 weeks on a normal diet. Dietary manipulation provided no added benefit over corticosteroid treatment on any outcome measure during the 16-week intervention or up to 1-year follow-up. For example, logistic regression showed no significant difference between normal and low microparticle groups for Crohn's disease activity index-based rates of remission (P=0.1) or clinical response (P=0.8).

Lomer MC, Grainger SL, Ede R, et al. Eur J Gastroenterol Hepatol, 2005. PMID 15716665

2005 / Interventional crossover study

In healthy adults, commonly consumed amounts of fructose (25 g and 50 g) frequently led to malabsorption and may result in mild gastrointestinal distress.

Fifteen normal volunteers consumed 25 g and 50 g doses of crystalline fructose with water after an overnight fast on separate test days. More than half of participants showed fructose malabsorption after 25 g, and over two thirds showed malabsorption after 50 g, with breath hydrogen AUC being significantly greater after the 50-g dose. Overall symptom scores were significantly higher than baseline after each dose, though only marginally greater after 50 g versus 25 g; peak hydrogen levels and AUC did not significantly correlate with symptoms.

Beyer PL, Caviar EM, McCallum RW J Am Diet Assoc, 2005. PMID 16183355

2005 / Uncontrolled clinical trial

Curcumin treatment showed preliminary improvements in small pilot trial of inflammatory bowel disease.

Ten patients with inflammatory bowel disease received a pure curcumin preparation in an open-label pilot study. All five patients with ulcerative proctitis improved, with four reducing concurrent medications. Additionally, four of five patients with Crohn's disease had lower Crohn's Disease Activity Index scores and sedimentation rates.

Holt PR, Katz S, Kirshoff R Dig Dis Sci, 2005. PMID 16240238